Keisean Nixon is definitely enjoying this offseason after his best season to date. Although, ironically, this is the first time in three years that he has not made the 1st team All-Pro – the previous ...

In this four-part video series highlighted below, Skye discusses unmet needs in the obesity therapeutic space, advantages and benefits of its peripheral CB1-receptor-targeting antibody, which is ...